Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply.
Domains
Santé publique et épidémiologieOrigin | Files produced by the author(s) |
---|---|
Licence |
_ |
Origin | Files produced by the author(s) |
---|---|
Licence |
Gestionnaire HAL 3 Sorbonne Université : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03776245
Submitted on : Tuesday, September 13, 2022-3:10:47 PM
Last modification on : Thursday, November 7, 2024-2:21:37 PM
Long-term archiving on : Wednesday, December 14, 2022-6:25:08 PM